浏览全部资源
扫码关注微信
1.广东药科大学中药学院,广州 510006
2.广东药科大学实验动物中心,广州 510006
3.广州市新药筛选模型系统建设与应用重点实验室,广州 510006
4.广东省局部精确给药系统工程中心,广州 510006
硕士研究生。研究方向:中药药效评价与临床应用。E-mail:1045002556@qq.com
教授,硕士生导师。研究方向:中药药效与安全性评价。E-mail:tchp66@163.com
纸质出版日期:2022-11-15,
收稿日期:2022-04-01,
修回日期:2022-09-12,
扫 描 看 全 文
陈聪,庄素琪,江涛等.黄绵马酸BB对MRSA和MSSA的体内外抗菌作用研究 Δ[J].中国药房,2022,33(21):2615-2621.
CHEN Cong,ZHUANG Suqi,JIANG Tao,et al.Study on antibacterial effects of flavaspidic acid BB against MRSA and MSSA in vitro and in vivo[J].ZHONGGUO YAOFANG,2022,33(21):2615-2621.
陈聪,庄素琪,江涛等.黄绵马酸BB对MRSA和MSSA的体内外抗菌作用研究 Δ[J].中国药房,2022,33(21):2615-2621. DOI: 10.6039/j.issn.1001-0408.2022.21.10.
CHEN Cong,ZHUANG Suqi,JIANG Tao,et al.Study on antibacterial effects of flavaspidic acid BB against MRSA and MSSA in vitro and in vivo[J].ZHONGGUO YAOFANG,2022,33(21):2615-2621. DOI: 10.6039/j.issn.1001-0408.2022.21.10.
目的
2
探究黄绵马酸BB对皮肤和软组织感染主要致病菌耐甲氧西林金黄色葡萄球菌(MRSA)和甲氧西林敏感金黄色葡萄球菌(MSSA)的体内外抗菌作用。
方法
2
采用微量稀释法测定黄绵马酸BB对10株MRSA和13株MSSA的最小抑菌浓度(MIC)和最小杀菌浓度(MBC),采用平板法绘制MRSA11和MSSA23菌株的时间-杀菌曲线,采用棋盘稀释法测定黄绵马酸BB与莫匹罗星的联用抑菌效果;建立小鼠皮肤脓肿模型,评价0.5%、1%、2%黄绵马酸BB乳膏对MRSA11、MSSA23菌株的体内抗菌作用;采用扫描电镜观察黄绵马酸BB对MRSA11、MSSA23菌株形态的影响,并检测两种菌株的核酸外渗含量和胞外蛋白含量。
结果
2
黄绵马酸BB对10株MRSA的MIC为6.30~80.00 μg/mL,MBC为40.00~640.00 μg/mL;对13株MSSA的MIC为40.00~80.00 μg/mL,MBC为63.50~126.99 μg/mL。黄绵马酸BB干预MRSA11、MSSA23菌株36 h后,杀菌率可达99.9%。黄绵马酸BB与莫匹罗星联用对MRSA菌株的作用为相加,对MSSA菌株的作用为相加或协同。0.5%、1%、2%黄绵马酸BB乳膏均能在一定程度上减小皮肤脓肿模型小鼠皮肤脓肿体积和降低细菌含量(
P
<0.05),改善模型小鼠皮肤脓肿部位的炎症病理变化。黄绵马酸BB可使MRSA11、MSSA23菌体细胞皱缩、破裂以及核酸外渗含量和胞外蛋白含量显著升高(
P
<0.01)。
结论
2
黄绵马酸BB对MRSA、MSSA均具有良好的体内外抗菌作用,其机制可能与改变细胞膜通透性有关。
OBJECTIVE
2
To investigate the antibacterial activities of flavaspidic acid BB against the main pathogens of skin and soft tissue infections such as methicillin-resistant
Staphylococcus aureus
(MRSA) and methicillin-sensitive
Staphylococcus aureus
(MSSA)
in vitro
and
in vivo
.
METHODS
2
Microdilution method was used to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of flavaspidic acid BB on 10 strains of MRSA and 13 strains of MSSA; time-kill curves of MRSA11 and MSSA23 strains were drawn by plate method; the checkerboard dilution method was used to determine the combined antibacterial effect of flavaspidic acid BB and mupirocin; the skin abscess model of mice was established to evaluate the antibacterial effects of 0.5%, 1%, 2% flavaspidic acid BB cream on MRSA11 or MSSA23 strains
in vivo
; scanning electron microscopy was used to observe the effects of flavaspidic acid BB on the morphology of MRSA11 or MSSA23 strains. The contents of nucleic acid leakage and extracellular protein were also determined.
RESULTS
2
MIC and MBC ranges of flavaspidic acid BB against 10 strains of MRSA were 6.30-80.00 μg/mL and 40.00-640.00 μg/mL; MIC and MBC ranges of 13 strains of MSSA were 40.00-80.00 μg/mL and 63.50-126.99 μg/mL, respectively. The bactericidal rate of MRSA11 and MSSA23 strains were 99.9% after interfered with plavaspidic acid BB for 36 h. The combination of flavaspidic acid BB and mupirocin showed an additive effect on MRSA strain and an additive or synergistic effect on MSSA strain. The 0.5%, 1% and 2% flavaspidic acid BB cream could reduce the volume of abscess and the bacterial load of skin abscess model mice to some extent (
P
<0.05), and improved the pathological changes of skin inflammation in skin abscess site of mice. Flavaspidic acid BB could make MRSA11 and MSSA23 cells shrinkage and rupture, and significantly increase the contents of nucleic acid leakage and extracellular protein (
P
<0.01).
CONCLUSIONS
2
Flavaspidic acid BB shows good antibacterial effect on MRSA and MSSA
in
vitro
and
in vivo
, the mechanism of which may be related to the change of membrane permeability.
黄绵马酸BB皮肤和软组织感染耐甲氧西林金黄色葡萄球菌甲氧西林敏感金黄色葡萄球菌抗菌皮肤脓肿
skin and soft tissue infectionsmethicillin-resistant Staphylococcus aureusmethicillin-sensitive Staphylococcus aureusantibacterial activityskin abscess
PETRAKIS V,PANAGOPOULOS P,PAPANAS N. Dalbavancin for the treatment of complicated gram-positive skin and soft tissue infections[J]. Int J Low Extrem Wounds,2020,19(3):236-241.
姬粉芝.金黄色葡萄球菌感染性皮肤病的外用抗生素选择[J].皮肤病与性病,2018,40(1):107-108.
BARBER M. Methicillin-resistant staphylococci[J]. J Clin Pathol,1961,14:385-393.
武杰,赵建平.耐甲氧西林金黄色葡萄球菌分型方法研究进展[J].中国感染与化疗杂志,2021,21(2):235-240.
ELFEKY D S,AWAD A R,ELSHOBAKY M A,et al. Effect of ceftaroline,vancomycin,gentamicin,macrolides,and ciprofloxacin against methicillin-resistant Staphylococcus aureus isolates:an in vitro study[J]. Surg Infect (Larchmt),2020,21(2):150-157.
YU F Y,LIU Y L,LU C H,et al. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates[J]. BMC Microbiol,2015,15:210.
DADASHI M,HAJIKHANI B,DARBAN-SAROKHALIL D,et al. Mupirocin resistance in Staphylococcus aureus:a systematic review and meta-analysis[J]. J Glob Antimicrob Resist,2020,20:238-247.
翟贯星,陆璐,陈代杰,等.中药化合物的抗菌及增效作用[J].中国抗生素杂志,2019,44(12):1366-1370.
王梁凤,李慧婷,陈青垚,等.中药挥发油抗菌作用的研究进展[J].中国中药杂志,2021,46(5):1026-1033.
韩旭阳,曾祖平,何秀娟,等.香鳞毛蕨中1个新的间苯三酚苷类化合物[J].中草药,2022,53(1):14-17.
梁玉婷,宋国强,林楚怡,等.香鳞毛蕨化学成分及其体外抗浅部真菌活性研究[J].天然产物研究与开发,2019,31(10):1758-1763.
殷川平,陈文浩,莫梓童,等.黄绵马酸BB对皮肤软组织感染致病菌的抗菌活性及机制研究[J].中草药,2021,52(6):1662-1667.
莫梓童,吴小诗,殷川平,等.黄绵马酸BB对革兰阳性致病菌的抗菌活性和生物被膜清除作用研究[J].中草药,2021,52(8):2324-2330.
SKARIYACHAN S,MUDDEBIHALKAR A G,BADRINATH V,et al. Natural epiestriol-16 act as potential lead mole- cule against prospective molecular targets of multidrug resistant Acinetobacter baumannii-insight from in silico modelling and in vitro investigations[J]. Infect Genet Evol,2020,82:104314.
PURKAIT S,BHATTACHARYA A,BAG A,et al. Eva- luation of antibiofilm efficacy of essential oil components β-caryophyllene,cinnamaldehyde and eugenol alone and in combination against biofilm formation and preformed biofilms of Listeria monocytogenes and Salmonella typhimurium[J]. Lett Appl Microbiol,2020,71(2):195-202.
周晓元,罗润齐,王俊洁,等.盐酸小檗碱联合喹诺酮对产超广谱β内酰胺酶肺炎克雷伯菌的体外抑菌作用的研究[J].现代医院,2021,21(10):1613-1618.
梁玉婷,刘小赟,潘敬灵,等.不同透皮吸收促进剂对黄绵马酸BB乳膏体外透皮吸收的影响[J].中国药房,2020,31(5):590-594.
WU T,HUANG Y N,CHEN Y J,et al. Antibacterial effect of (2E,2E)-4,4-trisulfanediylbis(but-2-enoic acid) against Staphylococcus aureus[J]. PLoS One,2018,13(5):e0197348.
HU W,LI C Z,DAI J M,et al. Antibacterial activity and mechanism of Litsea cubeba essential oil against methicillin-resistant Staphylococcus aureus (MRSA)[J]. Ind Crops Prod,2019,130:34-41.
HE N,WANG P Q,WANG P Y,et al. Antibacterial mechanism of chelerythrine isolated from root of Toddalia asiatica (Linn) Lam[J]. BMC Complement Altern Med,2018,18(1):261.
LIU Q Q,HAN J,ZUO G Y,et al. Potentiation activity of multiple antibacterial agents by Salvianolate from the Chinese medicine Danshen against methicillin-resistant Staphylococcus aureus (MRSA)[J]. J Pharmacol Sci,2016,131(1):13-17.
江炜,邹国发,古炽明,等.小鼠皮肤脓肿模型构建及多枝雾水葛的药效评价[J].医药导报,2020,39(3):298-304.
胡付品,郭燕,朱德妹,等. 2019年CHINET三级医院细菌耐药监测[J].中国感染与化疗杂志,2020,20(3):233-243.
朱冲冲,彭冰,曾祖平,等.香鳞毛蕨的化学成分及药理作用研究进展[J].中国药房,2017,28(10):1418-1423.
孙宇豪,陈恬,林皓楠,等.截短侧耳素衍生物ZYY-12h对MRSA菌株的抑菌作用及作用机制研究[J].中国抗生素杂志,2022,47(1):22-27.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构